Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Obesity and overweight are estimated to have caused a staggering $30.1 billion reduction in Florida economy in 2022, equivalent to 2.2% of the state's gross domestic product, according to a...
Obesity and overweight are estimated to have caused a staggering $89.5 billion reduction in California economy in 2022, equivalent to 2.5% of the state's gross domestic product, according to a...
Obesity and overweight are estimated to have caused a staggering $19.9 billion reduction in Pennsylvania’s economy in 2022, equivalent to 2.2% of the state's gross domestic product, according to...
Obesity and overweight are estimated to have caused a staggering $7.2 billion reduction in Alabama’s economy in 2022, equivalent to 2.6% of the state's gross domestic product, according to a...
Obesity and overweight are estimated to have caused a staggering $17.6 billion reduction in Illinois’ economy in 2022, equivalent to 1.7% of the state's gross domestic product, according to a...
Obesity and overweight are estimated to have caused a staggering $425.5 billion in economic costs to U.S. businesses and employees in 2023, according to a report released by GlobalData Plc, a...
Obesity and overweight are estimated to have caused a staggering $5.7 billion reduction in Iowa’s economy in 2022, equivalent to 2.5% of the state's gross domestic product, according to a report...
Obesity and overweight are estimated to have caused a staggering $37.3 billion reduction in New York’s economy in 2022, equivalent to 1.8% of the state's gross domestic product, according to a...
Obesity and overweight are estimated to have caused a staggering $9.3 billion reduction in Indiana's economy in 2022, equivalent to 2% of the state's gross domestic product, according to a report...
Presenting companies include: Teva Pharmaceuticals Industries, BioForum, Pharma Focus Israel and DATATRAK International CLEVELAND, Feb. 9 /PRNewswire-FirstCall/ -- DATATRAK International, Inc...
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
Jack_Herer
3分前
quester614
4分前
jaws57
6分前
MetaMonster
6分前
Monksdream
7分前
zab
7分前
madeindet
8分前
bar1080
8分前
bar1080
8分前
Dingbatt
8分前
Monksdream
9分前
zab
9分前
MetaMonster
10分前
Ex-brokerBry
10分前
Bigfootbud
11分前
stockinspector
11分前
Susie924
11分前
choo choo trader
13分前
DTGoody
13分前
Monksdream
14分前
StockItOut
15分前
Malibew66
16分前
frrol
17分前
hbhmb
18分前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
